This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Company | Broker Update |
| Anglo American | HSBC cuts TP to 1610p from 2250p; Overweight |
| Antofagasta | HSBC cuts TP to 900p from 1080p; Neutral |
| BHP Bliton | HSBC cuts TP tp 1990p from 2110p; Overweight |
| Bovis Homes | Panmure Gordon ups TP to 778p from 714p; Hold |
| Computacenter | Panmure Gordon downgrades to Hold from Buy; TP 474p |
| Computacenter | Investec ups TP 550p to 480p; Buy |
| CRH | UBS cuts TP to 1330p from 1350p; Neutral |
| Dechra Pharma | Finncap upgrades to Buy; TP 800p |
| EnQuest | Westhouse downgrades to nuetral from Buy |
| Galiford Try | Panmure Gordon ups TP to 895p from 870p; Sell |
| GlaxoSmithKline | Morgan Stanley ups TP to 1710p from 1370p; Equalweight |
| Invensys | Canaccord Genuity ups TP to 505p from 420p; Hold |
| Kingfisher | Deutsche Bank ups TP to 360p from 325p; Hold |
| Persimmon | Panmure Gordon ups TP to 995p from 970p; Sell |
| Reckitt Benckiser | HSBC cuts TP to 4800p from 4900p; Neutral |
| Redrow | Pamure Gordon ups TP to 214p from 211p; Hold |
| Rio Tinto | HSBC cuts TP to 4070p from 4160p; Overwight |
| Salamander Energy | Deutsche Bank cuts TP to 207p from 220p. |
| Savills | UBS ups TP to 660p from 610p; Buy |
| United Utilities | Deutsche Bank cuts TP to 800p from 850p; Buy |
| Vedanta | HSBC cuts TP to 1220p from 1280p; Neutral |
| Vedanta | RBC Capital Markets downgrades to Underperform from Sectorperform |
| Vedanta | RBC Capital Markets cuts TP to 1100p from 1200p |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research